270 related articles for article (PubMed ID: 24785322)
21. Cs-131 brachytherapy for patients with recurrent glioblastoma combined with bevacizumab avoids radiation necrosis while maintaining local control.
Wernicke AG; Taube S; Smith AW; Herskovic A; Parashar B; Schwartz TH
Brachytherapy; 2020; 19(5):705-712. PubMed ID: 32928486
[TBL] [Abstract][Full Text] [Related]
22. Stereotactic radiosurgery for intracranial hemangiopericytomas: a multicenter study.
Cohen-Inbar O; Lee CC; Mousavi SH; Kano H; Mathieu D; Meola A; Nakaji P; Honea N; Johnson M; Abbassy M; Mohammadi AM; Silva D; Yang HC; Grills I; Kondziolka D; Barnett GH; Lunsford LD; Sheehan J
J Neurosurg; 2017 Mar; 126(3):744-754. PubMed ID: 27104850
[TBL] [Abstract][Full Text] [Related]
23. Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastases.
Imber BS; Young RJ; Beal K; Reiner AS; Giantini-Larsen AM; Krebs S; Yang JT; Aramburu-Nunez D; Cohen GN; Brennan C; Tabar V; Moss NS
J Neurooncol; 2022 Sep; 159(3):609-618. PubMed ID: 35896906
[TBL] [Abstract][Full Text] [Related]
24. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
[TBL] [Abstract][Full Text] [Related]
25. Intracranial control and radiographic changes with adjuvant radiation therapy for resected brain metastases: whole brain radiotherapy versus stereotactic radiosurgery alone.
Patel KR; Prabhu RS; Kandula S; Oliver DE; Kim S; Hadjipanayis C; Olson JJ; Oyesiku N; Curran WJ; Khan MK; Shu HK; Crocker I
J Neurooncol; 2014 Dec; 120(3):657-63. PubMed ID: 25189789
[TBL] [Abstract][Full Text] [Related]
26. The cost-effectiveness of surgical resection and cesium-131 intraoperative brachytherapy versus surgical resection and stereotactic radiosurgery in the treatment of metastatic brain tumors.
Wernicke AG; Yondorf MZ; Parashar B; Nori D; Clifford Chao KS; Boockvar JA; Pannullo S; Stieg P; Schwartz TH
J Neurooncol; 2016 Mar; 127(1):145-53. PubMed ID: 26725100
[TBL] [Abstract][Full Text] [Related]
27. Clinical outcomes of gastrointestinal brain metastases treated with radiotherapy.
Sanghvi SM; Lischalk JW; Cai L; Collins S; Nair M; Collins B; Unger K
Radiat Oncol; 2017 Feb; 12(1):43. PubMed ID: 28245881
[TBL] [Abstract][Full Text] [Related]
28. Management of newly diagnosed single brain metastasis with surgical resection and permanent I-125 seeds without upfront whole brain radiotherapy.
Petr MJ; McPherson CM; Breneman JC; Warnick RE
J Neurooncol; 2009 May; 92(3):393-400. PubMed ID: 19357965
[TBL] [Abstract][Full Text] [Related]
29. Survival after surgery and stereotactic radiosurgery for patients with multiple intracranial metastases: results of a single-center retrospective study.
Smith TR; Lall RR; Lall RR; Abecassis IJ; Arnaout OM; Marymont MH; Swanson KR; Chandler JP
J Neurosurg; 2014 Oct; 121(4):839-45. PubMed ID: 24857242
[TBL] [Abstract][Full Text] [Related]
30. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
31. Postoperative stereotactic radiosurgery without whole-brain radiation therapy for brain metastases: potential role of preoperative tumor size.
Hartford AC; Paravati AJ; Spire WJ; Li Z; Jarvis LA; Fadul CE; Rhodes CH; Erkmen K; Friedman J; Gladstone DJ; Hug EB; Roberts DW; Simmons NE
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):650-5. PubMed ID: 22795806
[TBL] [Abstract][Full Text] [Related]
32. Impact of regular magnetic resonance imaging follow-up after stereotactic radiotherapy to the surgical cavity in patients with one to three brain metastases.
Bachmann N; Leiser D; Ermis E; Vulcu S; Schucht P; Raabe A; Aebersold DM; Herrmann E
Radiat Oncol; 2019 Mar; 14(1):45. PubMed ID: 30871597
[TBL] [Abstract][Full Text] [Related]
33. Intraoperative brachytherapy for resected brain metastases.
Mahase SS; Navrazhina K; Schwartz TH; Parashar B; Wernicke AG
Brachytherapy; 2019; 18(3):258-270. PubMed ID: 30850332
[TBL] [Abstract][Full Text] [Related]
34. Brachytherapy as an Adjuvant for Recurrent Atypical and Malignant Meningiomas.
Koch MJ; Agarwalla PK; Royce TJ; Shih HA; Oh K; Niemierko A; Mauceri TC; Curry WT; Barker FG; Loeffler JS
Neurosurgery; 2019 Nov; 85(5):E910-E916. PubMed ID: 31329941
[TBL] [Abstract][Full Text] [Related]
35. Stereotatic radiosurgery of 468 brain metastases < or =2 cm: implications for SRS dose and whole brain radiation therapy.
Shehata MK; Young B; Reid B; Patchell RA; St Clair W; Sims J; Sanders M; Meigooni A; Mohiuddin M; Regine WF
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):87-93. PubMed ID: 15093903
[TBL] [Abstract][Full Text] [Related]
36. Phase I trial of gross total resection, permanent iodine-125 brachytherapy, and hyperfractionated radiotherapy for newly diagnosed glioblastoma multiforme.
Chen AM; Chang S; Pouliot J; Sneed PK; Prados MD; Lamborn KR; Malec MK; McDermott MW; Berger MS; Larson DA
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):825-30. PubMed ID: 17512132
[TBL] [Abstract][Full Text] [Related]
37. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.
Sneed PK; Mendez J; Vemer-van den Hoek JG; Seymour ZA; Ma L; Molinaro AM; Fogh SE; Nakamura JL; McDermott MW
J Neurosurg; 2015 Aug; 123(2):373-86. PubMed ID: 25978710
[TBL] [Abstract][Full Text] [Related]
38. Comparison of stereotactic brachytherapy (125 iodine seeds) with stereotactic radiosurgery (LINAC) for the treatment of singular cerebral metastases.
Ruge MI; Kocher M; Maarouf M; Hamisch C; Treuer H; Voges J; Sturm V
Strahlenther Onkol; 2011 Jan; 187(1):7-14. PubMed ID: 21234527
[TBL] [Abstract][Full Text] [Related]
39. Stereotactic radiosurgery for brain metastases: a case-matched study comparing treatment results for patients 80 years of age or older versus patients 65-79 years of age.
Watanabe S; Yamamoto M; Sato Y; Kawabe T; Higuchi Y; Kasuya H; Yamamoto T; Matsumura A; Barfod BE
J Neurosurg; 2014 Nov; 121(5):1148-57. PubMed ID: 25061863
[TBL] [Abstract][Full Text] [Related]
40. Resection with intraoperative cesium-131 brachytherapy as salvage therapy for recurrent brain tumors.
Chen WC; Lafreniere M; Phuong C; Liu SJ; Baal JD; Lometti M; Morin O; Ziemer B; Vasudevan HN; Lucas CG; Hervey-Jumper SL; Theodosopoulos PV; Magill ST; Fogh S; Nakamura JL; Boreta L; Sneed PK; McDermott MW; Raleigh DR; Braunstein SE
J Neurosurg; 2022 Oct; 137(4):924-930. PubMed ID: 35061986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]